Brenna Hughes, MD, MSc, Division Director of Maternal Fetal Medicine at Duke University, discusses the hypothesis that cytomegalovirus hyperimmune globulin (CMV-HIG) could have an effect on stopping congenital infections, as well as results of the trial.

0 Comments